Chinese clinical-stage innovative drug developer Kangpu Biopharmaceuticals unveiled on Friday that it has raised nearly RMB100 million (US$14.18 million) in a series pre-B round of financing.
Chinese Clinical-Stage Innovative Drug Developer Kangpu Raises Nearly $14M comes originally from China Money Network. All Rights Reserved.
...This news article comes via China Money Network, who is the copyright owner of this information and news. FintekAsia.com has licensed the rights to this article and any republication or re-distribution in whole or in part of this content is strictly prohibited without the express consent of
